Last reviewed · How we verify

Assessment of Seizure Prophylaxis Protocols Using Intravenous Levetiracetam in a Neuroscience Intensive Care Unit (Keppra)

NCT00618436 Phase 4 COMPLETED Results posted

To show that the use of intravenous levetiracetam(LEV;Keppra)for seizure prevention in patients in the Neuroscience Intensive Care Unit will result in fewer side effects compared to the current standard of care anticonvulsant and will be at least as effective as the current standard of care in preventing clinical and sub-clinical seizure activity.

Details

Lead sponsorUniversity of Cincinnati
PhasePhase 4
StatusCOMPLETED
Enrolment52
Start date2007-08
Completion2009-09

Conditions

Interventions

Primary outcomes

Countries

United States